CN112107881A - Device for saponifying and extracting ergosterol - Google Patents
Device for saponifying and extracting ergosterol Download PDFInfo
- Publication number
- CN112107881A CN112107881A CN202011101897.9A CN202011101897A CN112107881A CN 112107881 A CN112107881 A CN 112107881A CN 202011101897 A CN202011101897 A CN 202011101897A CN 112107881 A CN112107881 A CN 112107881A
- Authority
- CN
- China
- Prior art keywords
- extraction
- tank
- ergosterol
- heavy phase
- stirring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 title claims abstract description 152
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 title claims abstract description 152
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 title claims abstract description 152
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 title claims abstract description 152
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 title claims abstract description 152
- 238000000605 extraction Methods 0.000 claims abstract description 278
- 238000003756 stirring Methods 0.000 claims abstract description 89
- 238000010438 heat treatment Methods 0.000 claims description 73
- 238000007127 saponification reaction Methods 0.000 claims description 44
- 238000006243 chemical reaction Methods 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- 238000004140 cleaning Methods 0.000 claims description 11
- 238000009826 distribution Methods 0.000 claims description 10
- 239000011521 glass Substances 0.000 claims description 10
- 238000005265 energy consumption Methods 0.000 abstract description 11
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 85
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 60
- 239000002904 solvent Substances 0.000 description 59
- 239000000706 filtrate Substances 0.000 description 52
- 239000000047 product Substances 0.000 description 52
- 238000001914 filtration Methods 0.000 description 49
- 239000000463 material Substances 0.000 description 46
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 42
- 238000005191 phase separation Methods 0.000 description 40
- 238000000855 fermentation Methods 0.000 description 35
- 230000004151 fermentation Effects 0.000 description 35
- 239000007788 liquid Substances 0.000 description 35
- 239000012043 crude product Substances 0.000 description 33
- 238000000034 method Methods 0.000 description 31
- 230000000694 effects Effects 0.000 description 29
- 238000001816 cooling Methods 0.000 description 27
- 238000001953 recrystallisation Methods 0.000 description 26
- 239000007787 solid Substances 0.000 description 23
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 22
- 230000008569 process Effects 0.000 description 22
- 229930182555 Penicillin Natural products 0.000 description 20
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 20
- 229940049954 penicillin Drugs 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 238000002425 crystallisation Methods 0.000 description 19
- 230000008025 crystallization Effects 0.000 description 19
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 16
- 239000000243 solution Substances 0.000 description 15
- 238000003828 vacuum filtration Methods 0.000 description 15
- 238000004519 manufacturing process Methods 0.000 description 14
- 238000002156 mixing Methods 0.000 description 14
- 238000005086 pumping Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 12
- 239000013078 crystal Substances 0.000 description 11
- 239000002994 raw material Substances 0.000 description 10
- 238000000967 suction filtration Methods 0.000 description 10
- 238000005303 weighing Methods 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 238000010586 diagram Methods 0.000 description 8
- 238000007599 discharging Methods 0.000 description 8
- 239000003208 petroleum Substances 0.000 description 8
- 239000012065 filter cake Substances 0.000 description 7
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical group CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 241000233866 Fungi Species 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 229960001701 chloroform Drugs 0.000 description 5
- 239000012535 impurity Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 238000001291 vacuum drying Methods 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 238000009776 industrial production Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000007670 refining Methods 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000032798 delamination Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 235000021190 leftovers Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 238000010977 unit operation Methods 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- 239000010963 304 stainless steel Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 101100390535 Mus musculus Fdft1 gene Proteins 0.000 description 1
- 101100390536 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) erg-6 gene Proteins 0.000 description 1
- 229910000589 SAE 304 stainless steel Inorganic materials 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 238000010835 comparative analysis Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 230000005574 cross-species transmission Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 101150116391 erg9 gene Proteins 0.000 description 1
- 230000008686 ergosterol biosynthesis Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 235000013547 stew Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
Images
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D11/00—Solvent extraction
- B01D11/02—Solvent extraction of solids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D36/00—Filter circuits or combinations of filters with other separating devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0053—Details of the reactor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/18—Stationary reactors having moving elements inside
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/10—Process efficiency
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Extraction Or Liquid Replacement (AREA)
Abstract
The invention discloses a device for saponifying and extracting ergosterol, which comprises an extraction tank, wherein the extraction tank comprises a cylindrical upper cylinder body and a conical lower cylinder body which are connected up and down, the top of the extraction tank is provided with a feed inlet, the bottom of the extraction tank is provided with a discharge outlet, the center of the extraction tank is provided with a stirring device, and the inner wall of the extraction tank is provided with a flow baffle. The invention simplifies the extraction process, and has the advantages of short extraction time, low energy consumption in the extraction process, high product purity and the like.
Description
Technical Field
The invention belongs to the field of medical intermediates, and particularly relates to a device for saponifying and extracting ergosterol from fermentation mushroom dregs.
Background
Ergosterol is also known as ergosterol. Ergosterol is an important component of microbial cell membranes and plays an important role in ensuring the integrity of cell membranes, the activity of membrane-bound enzymes, membrane fluidity, cell viability, and cell mass transport. Ergosterol is a precursor for the production of vitamin D2 and also an intermediate for the production of hormonal drugs, and can be used to produce cortisone. Has vitamin D2 effect.
The traditional ergosterol synthesis method mainly adopts microbial fermentation assisted with traditional chemical synthesis and separation, the production process route of the ergosterol takes ERG9 as a starting point to prepare the ergosterol, and the process has the disadvantages of complicated steps, more side reactions, low space-time yield, difficult three-waste treatment and high production cost, and causes higher product price and insufficient market supply.
Some fungi, starch fermentation products and antibiotic fungi residues contain ergosterol, and can be extracted. The domestic patent CN201110067641 discloses a process for extracting high-purity ergosterol and feed protein from penicillin waste residues, which uses the penicillin waste residues as raw materials and obtains ergosterol products by circular extraction, concentration, saponification, extraction, crystallization separation, decoloration, crystallization separation and drying. The solvent used in the patent is a mixture of methanol and dichloromethane, the using amount of the solvent is 8 times of the mass of the raw materials, the saponifying agent is a sodium hydroxide solution with the mass fraction of 5% -35%, the extracting agent is a mixture of normal hexane and cyclohexane, and devices for saponifying and extracting ergosterol are more and the operation is complex. The domestic patent CN201010146406 discloses a method for extracting ergosterol by using mushroom leftovers, which comprises the steps of pretreating mushroom leftover raw materials, saponifying, filtering, extracting, washing, evaporating, concentrating, refining and the like to obtain an ergosterol finished product, wherein alkali-alcohol mixed solution is adopted in saponification, the alkali is sodium hydroxide or potassium hydroxide, the alcohol is methanol or ethanol, an extracting agent is No. 70 gasoline, and the ethanol is adopted in refining for crystallization. The extraction processes of the two patents are complex, and the devices for extracting the ergosterol by saponification have the disadvantages of more devices, low yield and high energy consumption. The domestic patent CN201810432608 discloses a method for extracting ergosterol from starch fermentation products, which takes the starch fermentation products as raw materials and obtains ergosterol products through the steps of saponification, filtration I, extraction, filtration II, decoloration, crystallization, recrystallization and the like. The solvent is methanol, the saponifying agent is sodium hydroxide, the extracting agent is ethyl acetate, and the recrystallization solvent is chloroform and ethanol. The extraction process of the patent has long flow and high energy consumption, and the device for extracting the ergosterol by saponification has complex operation.
Disclosure of Invention
Aiming at the problems and the defects in the prior art, the invention provides the device for saponifying and extracting the ergosterol, which greatly simplifies the extraction process, shortens the extraction time, reduces the consumption of the extraction process, improves the product quality and is very suitable for industrial mass production.
In order to achieve the purpose, the invention provides a device for extracting ergosterol by saponification, which comprises an extraction tank, wherein the extraction tank comprises a cylindrical upper cylinder body and a conical lower cylinder body which are connected up and down, a feed inlet is formed in the top of the extraction tank, a discharge outlet is formed in the bottom of the extraction tank, a stirring device is arranged in the center of the extraction tank, and a flow baffle is arranged on the inner wall of the extraction tank.
Preferably, the tank top of the extraction tank is further provided with an air outlet and a reflux port, the center of the tank bottom of the extraction tank is provided with a discharge port, and the discharge port of the extraction tank is connected with a discharge pump.
Preferably, agitating unit includes the (mixing) shaft, the one end of (mixing) shaft is connected with agitator motor, is located go up in the barrel (mixing) shaft upper portion is equipped with at least a set of stirring vane group, preferably is equipped with first blade group, second blade group and third blade group from top to bottom in proper order, is located in down in the barrel the lower part of (mixing) shaft is equipped with at least a set of stirring vane group, preferably is equipped with fourth blade group and fifth blade group, the blade group including two blade shape blades of symmetry, the blade of adjacent two sets of blade groups with the central axis contained angle of (mixing) shaft forms the antisymmetric arrangement.
Preferably, a plurality of flow baffle plates are vertically arranged on the inner wall of the upper cylinder of the extraction tank at intervals, more preferably, the flow baffle plates are circumferentially arranged at equal intervals along the inner wall of the upper cylinder of the extraction tank at equal angles, more preferably, the lower ends of the flow baffle plates extend to the joint of the inner wall of the upper cylinder and the inner wall of the lower cylinder, more preferably, at least one flow guide hole is arranged at the position, close to the inner wall of the upper cylinder of the extraction tank, of the flow baffle plates, preferably, 3-6 flow guide holes are arranged at equal intervals on the upper, middle and lower parts of the flow baffle plates along the length direction of the flow baffle plates, and the diameter of each flow guide hole is 50-100 mm.
Preferably, the bottom end of (mixing) shaft suit end bearing, the (mixing) shaft can rotate in the end bearing, end bearing fixed connection in draw the tank bottoms portion, more preferably end bearing pass through the fixed welding of connecting plate draw the tank bottoms portion, connecting plate one end is fixed end bearing's periphery, the other end is fixed draw the tank bottoms portion, more preferably end bearing through 3 connecting plate fixed welding for (mixing) shaft axis symmetric distribution draw the tank bottoms portion.
Preferably, a heating device, preferably a steam heating coil, is arranged on the inner wall of the extraction tank and/or the outer wall of the upper cylinder; more preferably, heating device is including setting up heating coil on the inner wall of the last barrel of extraction jar, installing steam distribution dish and comdenstion water catch tray on the outer wall of the last barrel of extraction jar, steam distribution dish pass through heating coil with comdenstion water catch tray intercommunication.
Preferably, the heating coil is arranged along the upper cylinder of the extraction tank in a longitudinally folded manner.
Preferably, draw and vertically set up 1 at least group heating coil on the barrel inner wall on the jar, more preferably along go up barrel inner wall circumference evenly sets up 4 ~ 8 groups heating coil at equal interval angle, heating coil's steam inlet pipe and steam outlet pipe set up draw on the jar barrel outer wall.
Preferably, heating coil's steam inlet pipe passes draw jar upper barrel wall and communicate the cover and establish draw jar ring type steam distribution on the body dish, heating coil's steam outlet pipe passes draw jar upper barrel wall and communicate the cover and establish draw jar ring type comdenstion water catch tray on the body, ring type comdenstion water catch tray is located ring type steam distribution dish below.
The steam pressure of the heating coil is 0.3-0.8 MP, and the temperature is 160-180 ℃.
Preferably, the extraction tank uses a variable frequency speed regulating motor to control a stirring shaft of the stirring device.
Preferably, the device for saponifying and extracting ergosterol further comprises a heavy phase balancing tank communicated with the extraction tank.
Preferably, the heavy phase balance tank is a closed cylindrical barrel, an exhaust port is formed in the top of the heavy phase balance tank, a feed inlet is formed in the middle or upper portion of the cylindrical barrel of the heavy phase balance tank, a heavy phase discharge port is formed in the center of the bottom of the heavy phase balance tank, and the feed inlet of the heavy phase balance tank is communicated with the discharge port of the extraction tank through a pipeline.
Preferably, the exhaust port of the heavy phase balancing tank is communicated with the top of the extraction tank, and more preferably, the exhaust port of the heavy phase balancing tank is communicated with the feed inlet of the extraction tank through an overflow pipe; the heavy phase discharge port of the heavy phase balancing tank is connected with a heavy phase pump through a heavy phase discharge pipe; more preferably, a viewing mirror opening is formed in the barrel body of the heavy phase balancing tank.
Preferably, an electric butterfly valve, a sight glass and an electric ball valve are sequentially installed at a discharge port at the bottom of the extraction tank through a pipeline, a light phase discharge pipeline and a cleaning pipeline are sequentially communicated on the pipeline between the electric butterfly valve and the sight glass, and the light phase discharge pipeline is connected with a light phase pump and used for conveying light phase extraction liquid; the cleaning pipeline is used for cleaning a discharge pipeline behind an electric butterfly valve at the bottom of the extraction tank, preferably, the cleaning pipeline is connected with nitrogen purging and/or solvent cleaning.
Preferably, the electric ball valve is connected with the feed inlet of the heavy phase balancing tank through a heavy phase discharge pipeline.
Preferably, the cylinder, the cone and the interface of the extraction tank and the heavy phase balance tank are all made of 304 stainless steel.
Preferably, the extraction tank and the heavy phase balancing tank are provided with a temperature detection point, a pressure detection point and a sampling point.
Preferably, the operation temperature of the saponification and extraction reaction of the extraction tank is 20-70 ℃, and more preferably 50-58 ℃.
Compared with the extraction device in the published similar patent, the device for extracting ergosterol by saponification has the following beneficial technical effects:
1) the process flow is simple, saponification and extraction are finished in one device, intermediate filtering, cooling, extraction and other steps are not needed, and the process flow is simplified; in addition, experiments show that 70-80% of ergosterol extracted by standing and phase splitting in an extraction tank can enter a light-phase extracting solution, compared with the method that the extract is filtered and then subjected to phase splitting after extraction reaction, the method has the advantages of small solvent volatilization loss, lower energy consumption, capability of reducing the operating pressure of subsequent phase splitting and reduction of phase splitting operating cost. In addition, the fermentation fungus dregs do not need to be pretreated before the solvent and the saponifier are added, and the extraction process is simplified.
2) The saponifier adopts solid sodium hydroxide, and no water is introduced, so that the wastewater amount and the energy consumption of subsequent separation are reduced. Add the saponifier after the solvent earlier, can prevent the saponifier and draw the problem that jar was drawed in the inner wall direct impact of jar, wearing and tearing when reinforced, stirring, can prevent simultaneously that the saponifier deposit from appearing at tank bottoms and pipeline, taking place the risk of blockking up.
3) N-heptane is preferably selected as an extractant, the extractant is layered with a solvent aqueous solution after extraction, the mass ratio of the preferred extractant dosage to the raw materials is 1-1.5, the dosage is greatly reduced, and the extractant consumption and the separation energy consumption in the concentration process are reduced.
4) The invention has short process flow, high extraction rate (ergosterol product quality/mushroom dreg raw material quality), stable extraction rate of more than 0.1 percent and highest extraction rate of 0.2 percent. The obtained ergosterol product has high purity which is not less than 98 wt%, and the product quality is superior to the product sold on the market at present.
5) Compared with the prior art, the extraction time is greatly shortened, the time from feeding to obtaining the ergosterol crude product is shortened from 24-36 hours to 12-15 hours, and the production capacity is improved by 1 time.
6) According to the ergosterol extraction, the heavy phase balance tank is designed to be matched with the extraction tank for use, so that stable material pumping can be ensured, the heavy phase is prevented from being sucked by the heavy phase discharge pump to generate impact force to damage a phase separation interface and a layering effect of a light phase and a heavy phase in the extraction tank when a valve at the bottom of the extraction tank is opened and the material is directly pumped by the heavy phase discharge pump after the material in the extraction tank is stood for layering to form the light phase and the heavy phase, the subsequent phase separation pressure is increased, and the standing and phase separation time is prolonged; the production cost is increased, and the production efficiency is reduced.
On the other hand, the gas vent of heavy phase compensating tank deck passes through the overflow pipe and draws the inlet pipe intercommunication of a jar tank deck, can also play the pressure that the jar and heavy phase compensating tank were drawed in the balance, prevent to draw the material in the jar after the layering that stews, when the heavy phase flow direction of jar heavy phase flows to heavy phase compensating tank, because of drawing a jar liquid level and being higher than the compensating tank, liquid level pressure difference is too big, lead to heavy phase compensating tank liquid to be full of fast, fall the top and spill over ground and cause environmental protection and material loss problem. The used solvent is flammable and explosive, the material is alkaline, and the tank overflow has potential safety hazards of combustion, explosion and alkali corrosion, so the tank overflow is not allowed to leak out of the tank. The exhaust port of the heavy phase balancing tank is communicated with the feed port of the extraction tank through an overflow pipe, so that the pressure difference of the two tank bodies can be balanced, and heavy phase liquid can directly flow back to the extraction tank through the overflow pipe when a roof fall emergency occurs; meanwhile, the heavy phase liquid quickly impacts the heavy phase balancing tank due to overlarge pressure difference, and the heavy phase balancing tank is damaged to cause safety accidents. In addition, when the heavy phase pump is started to pump the heavy phase material in the heavy phase balancing tank, when the liquid level of the heavy phase material in the heavy phase balancing tank is too low, the problem that the split-phase interface and the layering effect of the light and heavy phases in the extraction tank are damaged due to the impact force generated by the heavy phase pumped by the heavy phase discharging pump can also occur. At this moment, in order to avoid the influence, the liquid level of the heavy phase balancing tank needs to be ensured, a small amount of light phase can be supplemented to the heavy phase balancing tank through the overflow pipe, and the effect of light phase separation can not be influenced all the time in the process of transferring the material and the heavy phase.
7) The paddle type stirring motor arranged in the extraction tank has the function of variable frequency speed regulation, the stirring intensity can be set at any time, the stirring intensity is particularly enhanced when saponification and extraction are synchronous, and the saponification and extraction effects are greatly accelerated.
8) The vertical a plurality of fender flow boards that set up in interval on the cylindricality of drawing jar barrel inner wall, from the top down sets up multiunit paddle formula stirring vane on the (mixing) shaft, can change the stirring mode of drawing jar interior material, makes it all form the stirring in the axial of (mixing) shaft and radial, makes the saponification draw more abundant and the reaction of material contact more violent, and the saponification is drawed with higher speed, and is effectual.
9) The light phase generated by the standing and phase splitting of the extraction tank passes through the bag filter, so that solid particles, impurities, protein impurities and the like of macromolecules in the light phase can be filtered, the light phase filtrate enters the phase splitting tank again for phase splitting and decoloring treatment, and the impurities in the light phase are removed in a filtering mode, so that the using amount of decoloration activated carbon can be reduced, and the decoloration reaction time can be shortened.
Drawings
FIG. 1 is a schematic diagram of the ergosterol extraction tank of the present invention;
FIG. 2 is a schematic view of the ergosterol extraction tank heating apparatus of the present invention;
FIG. 3 is a schematic diagram of an ergosterol heavy phase equilibrium tank configuration of the present invention;
FIG. 4 is a schematic diagram showing the connection of an extraction tank and a heavy phase equalization tank in an ergosterol extraction unit according to the invention;
FIG. 5 is a schematic diagram of a process for extracting ergosterol from fermentation broth.
In the figure:
1-an extraction tank, 2-a heavy phase balance tank, 3-a discharge pipe, 4-a butterfly valve, 5-a sight glass, 6-a ball valve, 7-a light phase discharge pipeline, 8-a light phase pump, 9-a heavy phase discharge pipeline, 10-an upper cylinder and 11-a lower cylinder; 12-stirring device, 13-stirring motor, 14-feeding hole, 15-reflux hole, 16-exhaust hole, 17-baffle plate, 18-heating device, 19-discharging hole, 20-heavy phase balance tank top, 21-heavy phase balance tank body, 22-heavy phase balance tank bottom, 120-stirring shaft, 121-first blade group, 122-second blade group, 123-third blade group, 124-fourth blade group, 125-fifth blade group, 126-bottom bearing, 127-connecting plate, 180-heating coil, 181-steam inlet pipe, 182-steam outlet pipe, 183-steam distribution plate, 184-condensed water collection plate, 201-exhaust hole, 202-manhole, 203-overflow pipe, 211-view mirror hole, 212-feed inlet, 221-heavy phase discharge outlet, 222-discharge pipe and 223-heavy phase pump.
Detailed Description
In order to better explain the context of the invention, the invention is further described below by means of specific examples, which should not be construed as limiting the scope of the invention thereto, all features disclosed in the summary of the invention, or all steps of a method or process disclosed, may be combined in any way, except mutually exclusive features and/or steps. Any feature disclosed in this application may be replaced by alternative features serving equivalent or similar purposes, unless expressly stated otherwise. That is, unless expressly stated otherwise, each feature is only an example of a generic series of equivalent or similar features.
In describing embodiments of the present invention, the terms "longitudinal," "lateral," "upper," "lower," "front," "rear," "left," "right," "vertical," "horizontal," "top," "bottom," "inner," "outer," and the like are used in an orientation or positional relationship that is based on the orientation or positional relationship shown in the associated drawings, which is for convenience and simplicity of description only, and does not indicate or imply that the referenced device or element must have a particular orientation, be constructed and operated in a particular orientation, and thus, the above-described terms should not be construed as limiting the present invention.
The present invention is described in detail below with reference to the drawings and the specific embodiments, which are not repeated herein, but the embodiments of the present invention are not limited to the following embodiments.
Operating equipment of ergosterol extraction unit-extraction tank and heavy phase equilibrium tank
The ergosterol extraction unit operation equipment mainly comprises an extraction tank and a heavy phase balancing tank. Fig. 1 is a schematic diagram of the structure of an extraction tank of the present invention, fig. 2 is a schematic diagram of a heating device of the extraction tank of the present invention, fig. 3 is a schematic diagram of the structure of a heavy phase equilibrium tank of the present invention, and fig. 4 is a schematic diagram of the connection relationship between the extraction tank and the heavy phase equilibrium tank in an extraction unit of the present invention.
1. Extracting pot
As shown in fig. 1, the extracting tank 1 includes a cylindrical upper cylinder 10 and a conical lower cylinder 11 connected up and down, and the lower cylinder 11 may be provided in other shapes, such as an elliptical shape or a hemispherical shape. The central stirring device 12 is arranged at the center of the extraction tank 1, the flow baffle plate 17 is arranged on the inner wall of the extraction tank 1, the feed inlet 14, the return port 15 and the exhaust port 16 are arranged at the top of the extraction tank 1, and the discharge outlet 19 is arranged at the center of the bottom of the extraction tank 1. Reaction materials such as fermentation mushroom dregs, a solvent, a saponifier, an extractant and the like can be added into the extraction tank 1 through the feed inlet 14. The exhaust port 16 is used for discharging reaction tail gas, and the reflux port 15 is used for condensing and refluxing solvent steam generated in the extraction reaction.
As shown in fig. 1, the stirring device 12 includes a stirring shaft 120, one end of the stirring shaft 120 is connected with a stirring motor 13, the upper portion of the stirring shaft 120 located in the upper cylinder 10 is sequentially provided with a first blade group 121, a second blade group 122 and a third blade group 123 from top to bottom, the lower portion of the stirring shaft 120 located in the lower cylinder 11 is provided with a fourth blade group 124 and a fifth blade group 125, all the blade groups include two blades symmetrically arranged along the central axis of the stirring shaft 120, preferably blade-shaped blades, the blade planes of the two adjacent blade groups are arranged in a reverse direction with the central axis of the stirring shaft 120, the included angle is measured by observing the extraction tank 1 from the tank top to the tank bottom, for example, the included angle between the blades of the first blade group 121 and the central axis of the stirring shaft 120 is 60 degrees, the included angle between the blades of the second blade group 122 and the central axis of the stirring shaft 120 is 120 degrees, and the sum of the included angles is 180 degrees. The paddle-shaped blade arrangement is beneficial to forcibly stirring the materials in the extraction tank and enhancing the reaction among the solvent, the saponifier and the fermentation mushroom dregs.
The upper cylinder 10 of the extraction tank 1 is vertically provided with a plurality of baffle plates 17 at intervals, preferably, the baffle plates 17 are arranged along the inner wall of the upper cylinder 10 of the extraction tank 1 at equal intervals in circumferential direction, for example, 4 baffle plates 17 are arranged along the inner wall of the upper cylinder 10 of the extraction tank 1 at equal intervals in circumferential direction symmetrically, that is, the baffle plates are arranged along the inner wall of the upper cylinder 10 of the extraction tank 1 at equal intervals in circumferential direction by 90 degrees, and for enhancing the baffle turbulent flow effect, the lower end of the baffle plate 17 is extended to the joint between the inner wall of the upper cylinder 10 and the inner wall of the lower cylinder 11. Due to the arrangement of the flow baffle plate 17, when the stirring shaft 120 rotates to stir materials, the materials are blocked when centrifugal force generated by the rotation of the cylinder wall touches the flow baffle plate 17 on the inner wall of the upper cylinder 10, so that the materials are forced to move upwards along the surface of the flow baffle plate 17 to form an axial stirring effect, and then the materials and the radial movement of the materials generated by the rotation of the stirring shaft are overlapped to form turbulent flow, thereby accelerating the mixing degree of the materials and increasing the extraction effect in the stirring process. In order to avoid the influence on material mixing caused by dead angles during stirring, 3 flow guide holes (not shown in the figure) with the diameter of 50mm are arranged at the position, close to the inner wall of the upper cylinder body of the extraction tank 1, of the flow baffle plate 17 at equal intervals along the upper part, the middle part and the lower part of the flow baffle plate 17 in the length direction, and the flow guide holes can guide material fluid at the positions of the flow baffle plate and the inner wall of the upper cylinder body of the extraction tank to pass through at an accelerated speed, so that the material at the position is driven to be blended into turbulence formed by superposition of axial and radial movement of the material generated by rotation of the stirring.
As shown in fig. 1 and 2, in order to accelerate the saponification and extraction reaction, a heating device 18 is provided on the extraction tank 1, and the heating device 18 includes a heating coil 180 vertically provided on the inner wall of the upper barrel 10 of the extraction tank 1, a steam distribution plate 183 and a condensed water collection plate 184 mounted on the outer wall of the upper barrel 10 of the extraction tank 1. In this patent, as required, a plurality of sets of heating coils 180 are installed and arranged at equal angular intervals along the circumferential direction of the inner wall of the upper cylinder 10 of the extraction tank 1, for example, 8 sets of heating coils 180 are installed and arranged at 45-degree intervals along the circumferential direction of the inner wall of the upper cylinder 10 of the extraction tank 1. Because the heating coil 180 is vertically arranged on the inner wall of the upper barrel 10 of the extraction tank 1, the similar stirring and flow blocking effect of the flow blocking plate 17 can be achieved, so that the material mixing degree is accelerated, and the extraction effect in the stirring process is increased.
The solvent and the extractant generate gas in the heating reaction process of the extraction tank 1 due to heating and volatilization, the pressure in the extraction tank 1 can be increased, the saponification and extraction effects can be reduced on one hand, and the potential safety hazard can be generated on the other hand. In order to ensure the safe and stable operation of the extraction tank and the saponification and extraction effects, a backflow port 15 is arranged at the top of the extraction tank 1, and a backflow pipe (not shown in figure 1) with a heat exchange condenser is arranged in an upward extending manner from the backflow port 15, wherein the heat exchange condenser can be a plate heat exchanger. When the solvent or the extractant volatilizes, the solvent or the extractant enters the return pipe from the return port 15, is cooled and condensed in the heat exchange condenser and flows back to the extraction tank 1, so that the safety problem caused by heating and volatilization of the solvent and the extractant can be eliminated, and the normal operation of the extraction reaction is also ensured.
As shown in fig. 2, in this patent, the heating device 18 is a steam heating coil, the heating coil 180 penetrates through the wall of the upper cylinder 10 of the extraction tank 1 and is communicated with a steam distribution plate 183 through a steam inlet pipe 181, heat is supplied to saponification and extraction reactions by inputting hot steam, and the heating coil 180 penetrates through the wall of the upper cylinder 10 of the extraction tank 1 and is communicated with a condensed water collection plate 184 through a steam outlet pipe 182. After the hot steam exchanges heat with the material in the extraction tank 1 through the heating coil 180, the condensed water formed by cooling and condensing flows into the condensed water collecting tray 184 through the steam outlet pipe 182.
In order to accelerate the saponification and extraction reaction and shorten the reaction time, the extraction tank 1 uses a variable frequency speed regulating motor 13 to control the rotating speed of the stirring shaft 120.
Through the extraction tank of above-mentioned design, saponification and extraction reaction speed obviously obtain promoting by a wide margin, need not carry out secondary saponification, secondary extraction to the fermentation fungus sediment moreover, and primary saponification, extraction reaction just can realize having promoted greatly and having drawed production efficiency to the abundant extraction of ergosterol in the fermentation fungus sediment.
2. Heavy phase balancing tank
In the extraction process, the applicant finds that light phase and heavy phase are layered after the extraction tank is subjected to extraction and then stands for a period of time, but when materials are pumped, the heavy phase is impacted by the suction of a pump to damage the phase separation interface and the layering effect of the light phase and the heavy phase in the extraction tank, so that the difficulty of subsequent phase separation treatment is increased, and subsequent crystallization is influenced.
To solve this problem, the applicant has further developed an extraction unit, which is designed with a heavy phase balancing tank 2 communicating with the extraction tank 1.
As shown in fig. 3, the heavy phase balance tank 2 is a closed cylindrical barrel, the top 20 of the heavy phase balance tank is provided with an exhaust port 201 and a manhole 202, the middle or upper part of the cylindrical barrel 21 of the heavy phase balance tank 2 is provided with a feed inlet 212, the center of the bottom 22 of the heavy phase balance tank 2 is provided with a heavy phase discharge outlet 221, the heavy phase discharge outlet 221 of the heavy phase balance tank 2 is connected with a heavy phase pump 223 through a discharge pipe 222, and the barrel 21 of the heavy phase balance tank 2 is provided with a viewing mirror port 211 for observing the material condition in the heavy phase balance tank 2.
As shown in FIG. 4, the exhaust port 201 of the heavy phase equalization tank 2 communicates with the extraction tank 1 through an overflow pipe 203, and preferably the overflow pipe 203 is connected to the feed port 14 of the extraction tank 1. The tank bottom discharge port 19 of the extraction tank 1 is sequentially provided with an electric butterfly valve 4, a viewing mirror 5 and an electric ball valve 6 through a discharge pipe 3, a light phase discharge pipeline 7 and a cleaning pipeline (not shown) are sequentially communicated on a pipeline between the electric butterfly valve 4 and the viewing mirror 5, and the light phase discharge pipeline 7 is connected with a light phase pump 8 and used for conveying light phase extracting solution. The electric ball valve 6 is connected with the feed inlet of the heavy phase balancing tank 2 through a heavy phase discharge pipeline 9.
3. Extraction unit operation equipment after heavy phase containing equilibrium tank
As shown in fig. 4, in the production, the extraction tank 1 is kept stand after saponification extraction, the extract is naturally layered in the extraction tank 1 to form a light phase (ergosterol and extractant) and a heavy phase (solvent, water, hypha and wall-broken residue), an electric butterfly valve 4 and an electric ball valve 6 which are connected with a discharge pipe 3 on a discharge port 19 at the bottom of the extraction tank 1 are opened, and the heavy phase at the lower layer in the extraction tank 1 automatically flows into a heavy phase balancing tank 2 through a heavy phase discharge pipe 9. And a heavy phase pump 223 is connected to a discharge pipe 222 connected to the bottom of the heavy phase balance tank 2, and the heavy phase material is pumped to a subsequent unit for subsequent filtration and phase separation of the heavy phase. Observing the sight glass 5 connected on the material discharging pipe 3, when a light phase enters the sight glass 5, closing the electric butterfly valve 4, opening a cleaning pipeline valve communicated on a pipeline between the electric butterfly valve 4 and the sight glass 5, purging nitrogen in the material discharging pipe 3, and removing residual heavy phase materials in the material discharging pipe 3 to enter the heavy phase balance tank 2. And after the purging is finished, closing the electric ball valve 6 and the cleaning pipeline valve, re-opening the electric butterfly valve 4 connected to the discharge pipe 3 and the light phase pump 8 connected to the light phase discharge pipeline 7, and enabling the light phase in the extraction tank 1 to enter a subsequent unit through the light phase pump 8 to perform subsequent filtering and phase splitting operations on the light phase.
Because the heavy phase balancing tank 2 is arranged, when the heavy phase pumping is started, the heavy phase balancing tank 2 can play a role in temporarily storing and buffering the heavy phase, and the phenomenon that the heavy phase receives the impact force of the pump to damage the phase separation interface and the layering effect of the light phase and the heavy phase in the extraction tank 1 is eliminated. In addition, because the exhaust port 201 of the heavy phase balancing tank 2 is communicated with the top of the extraction tank 1 through the overflow pipe 203, for example, is communicated with the feed inlet 14 of the extraction tank 1, on one hand, the pressure difference generated by the difference of the liquid levels between the extraction tank 1 and the heavy phase balancing tank 2 can be balanced, for example, a light phase is introduced into the heavy phase balancing tank 2 through the overflow pipe 203 to keep a section of the liquid level in the overflow pipe 203 to generate a certain pressure, the impact force of the pump on the impact weight is received to damage the phase separation interface and the layering effect of the light phase and the heavy phase in the extraction tank 1, on the other hand, the problems of environmental protection and material loss caused by the fact that the liquid level of the heavy phase balancing tank 2 is higher than that of the heavy phase balancing tank 2 and the liquid level pressure difference is too large, the heavy phase balancing tank 2 is filled with the.
Process for extracting ergosterol
FIG. 5 is a schematic view of a process for extracting ergosterol from fermentation broth using the extraction apparatus of the present invention.
As shown in FIG. 5, the fermented residue from penicillin is directly added into the extraction tank of the extraction unit, the metered solvent is added, the heating device of the extraction tank is started, and the fermented residue and the solvent are heated and stirred. After the temperature is raised to the preset saponification temperature, the measured saponifying agent is added, and the mixture is continuously stirred to generate saponification reaction. Adding extractant, and heating and stirring to obtain extract containing ergosterol.
In an extraction tank, stopping stirring, maintaining the temperature of extraction reaction, standing the extracted reactants, naturally layering the reactants, wherein the lower layer is a heavy phase, the upper layer is a light phase, the heavy phase is mainly a mixture of methanol, water, protein, hypha, cell wall residues after saponification wall breaking and the like, the light phase is an n-heptane solution dissolved with ergosterol and a small amount of protein, and the light phase also contains a small amount of macromolecular solid particles.
Opening a discharge valve at the bottom of the extraction tank, discharging the heavy phase in the extraction tank into a heavy phase collection device (a heavy phase balance tank) through a heavy phase discharge pipeline, filtering the heavy phase by pumping, separating out the saponified wall-broken cell wall residue and heavy phase filtrate, and allowing the heavy phase filtrate to enter a subsequent phase-splitting tank for phase splitting; when the heavy phase in the extraction tank is completely discharged, switching to a light phase pipeline, discharging the light phase in the extraction tank into a light phase collection device through the light phase pipeline, filtering the light phase, separating large particle impurities and light phase filtrate in the light phase, and allowing the light phase filtrate to enter a subsequent phase-splitting tank for phase splitting.
The heavy phase filtrate and the light phase filtrate can be fed into a subsequent phase separation tank together for phase separation and standing delamination, or can be fed into different phase separation tanks separately for phase separation, and in actual production, the heavy phase filtrate and the light phase filtrate are preferably fed into different phase separation tanks separately for phase separation and standing delamination. Wherein, the solvent and the water (i.e. heavy phase) are separated from the lower layer of the phase separation tank and are continuously recovered and recycled to the extraction unit for use, and the upper layer liquid (i.e. light phase) containing the ergosterol and the extractant is separated from the upper layer of the phase separation tank and enters the crystallization unit for preparing the ergosterol.
As shown in fig. 5, the light phase enters a decoloring tank for decoloring, a decoloring agent (preferably activated carbon) is added, heating is carried out, decoloring is carried out under stirring, hot filtration is carried out, filtrate is collected, the collected filtrate is heated and distilled under negative pressure, and the condensing and recycling extractant is recycled to an extraction unit for use. And continuously cooling the concentrated solution, and filtering to obtain a solid ergosterol crude product. The hot filtering in the decolorization aims to avoid that part of the product is crystallized and separated out and a decolorizer is filtered together after the temperature of the filtrate is reduced, so that the extraction rate is influenced.
And adding the ergosterol crude product into a recrystallization container, adding a recrystallization solvent, heating until the crude product is completely dissolved, then cooling and crystallizing according to a program, filtering and drying to obtain the ergosterol product.
The ergosterol extracted from the fermentation fungus residues is saponified and extracted in the same reaction kettle, namely an extraction tank, so that the complex process operations of setting saponification and extraction reactions in different reaction kettles, filtering, cooling and re-heating in the middle are reduced in the prior art, the production process flow is simplified, and the production energy consumption can be reduced. In addition, the ergosterol extraction tank is used for standing and layering treatment, so that the effect of primary phase separation can be achieved, the extraction efficiency of the ergosterol can be improved, the whole extraction time is greatly shortened, intermediate operation links are reduced, the loss in the extraction of the ergosterol can be reduced, and the purity of an ergosterol crude product is improved to a certain extent.
The invention can be used for extracting the ergosterol by using the ergosterol contained in the penicillin fermentation mushroom dregs, and can also be used for extracting the ergosterol by using mushroom dregs produced by other similar antibiotics, but the ergosterol content is greatly different due to different strains and fermentation processes.
Method for detecting ergot product
1. Appearance detection
And detecting the appearance crystal form and color by naked eyes, and comparing with a standard substance.
2. Purity detection
A detection instrument: high Performance Liquid Chromatography (HPLC) with ultraviolet detector.
The detection method comprises the following steps: 100% methanol in fluidity; an appropriate amount of ergosterol was dissolved in methanol solvent without using ultrasonic waves. Extracting a proper amount of sample to be detected by using a microsyringe, injecting the sample to be detected into HPLC, detecting the wavelength of 281 nanometers, and detecting a column: conventional C18 column.
(IV) examples
The ergosterol extraction system of the present invention was selected to complete examples 1-9. By way of comparison, example 10 is completed with reference to CN 201810432608. The extraction raw material is penicillin fermentation bacteria residue with the water content of 70 percent.
Description of the experimental conditions: in each of examples 1 to 10, crystallization was carried out using a 100L glass reactor, a 50L separatory funnel, a mini centrifuge (for heavy phase filtration), a 25L rotary evaporator (for concentration), and a 20L crystallization vessel. The relevant results are illustrated below.
Example 1
(1) Extraction: weighing 1kg of penicillin fermentation residues, adding the penicillin fermentation residues into an extraction tank, adding 1.2kg of methanol, heating to maintain the temperature at 55 ℃, adding 70g of solid sodium hydroxide, stirring for 6 hours, then adding 1.2kg of petroleum ether, heating to maintain the temperature at 50 ℃, and stirring for 3 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the material subjected to the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing and layering, collecting upper layer light phase liquid, and recovering a lower layer solvent. Simultaneously, 0.5kg of filter cake is collected.
(3) Decoloring and crystallizing: and (3) adding the upper-layer liquid collected in the filtering and phase-splitting in the step (2) into a decoloring tank with a stirring device, maintaining the temperature at 50 ℃, adding 1g of activated carbon, stirring for 2 hours, filtering while hot, collecting filtrate, heating and distilling the collected filtrate under negative pressure, and condensing to recover petroleum ether. And cooling the concentrated solution to 10 ℃, and filtering to obtain 0.7g of white solid, namely the ergosterol crude product. The time required for concentration and crystallization was 2 hours.
The ergosterol extraction was 0.07% and the purity was analyzed to be 87%. The extraction time is greatly shortened, and the time from feeding to obtaining the crude product of the ergosterol is shortened to 13 hours, wherein the time for obtaining the ergosterol extract is 9 hours. The ergosterol product is observed to be white powder in appearance and slightly poor in crystal form.
Example 2
(1) Extraction: weighing 1kg of penicillin fermentation residues, adding the penicillin fermentation residues into an extraction tank, adding 1.2kg of methanol, heating to maintain the temperature at 55 ℃, adding 70g of solid sodium hydroxide, stirring for 6 hours, then adding 1.2kg of petroleum ether, heating to maintain the temperature at 50 ℃, and stirring for 3 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the material subjected to the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing and layering, collecting upper layer light phase liquid, and recovering a lower layer solvent. Simultaneously, 0.5kg of filter cake is collected.
(3) 2 times of extraction of filter cakes: adding 0.6kg of petroleum ether into the extraction tank, and then adding 0.5kg of filter cake generated after filtering and phase separation in the step (2); heating to 50 deg.C, stirring, and extracting at the same temperature for 2 hr.
(4) Filtering and phase separation: and (4) performing vacuum filtration on the material obtained after the 2-time extraction reaction of the filter cake in the step (3), collecting filtrate, pumping the filtrate into a phase separation tank, standing for layering, collecting upper-layer light-phase liquid, and recovering a lower-layer solvent.
(5) Decoloring and crystallizing: and (3) mixing the upper layer light phase liquid collected in the steps (2) and (4), adding the mixture into a decoloring tank with a stirring device, maintaining the temperature at 50 ℃, adding 1.5g of activated carbon, stirring for 2 hours, filtering while the mixture is hot, collecting filtrate, heating and distilling the collected filtrate under negative pressure, and condensing to recover petroleum ether. And cooling the concentrated solution to 10 ℃, and filtering to obtain 0.75g of white solid, namely the ergosterol crude product. The time required for concentration and crystallization was 2 hours.
The ergosterol extraction was 0.075% with an analytical purity of 87%. The extraction time is shortened, and the time from feeding to obtaining the ergosterol crude product is shortened to 15 hours, wherein the time for obtaining the ergosterol extract is 11 hours. The ergosterol product is observed to be white powder in appearance and slightly poor in crystal form.
Example 3
(1) Extraction: weighing 1kg of penicillin fermentation residues, adding into an extraction tank, adding 1.2kg of chloroform, heating to maintain the temperature at 57 ℃, adding 50g of sodium hydroxide, and stirring for 4 hours. 1.2kg of n-heptane was added thereto, and the mixture was heated to maintain the temperature at 50 ℃ and stirred for 3 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the material subjected to the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing and layering, collecting upper layer light phase liquid, and recovering a lower layer solvent.
(3) Decoloring and crystallizing: and (3) adding the upper layer light phase liquid collected in the filtering and phase splitting in the step (2) into a decoloring tank with a stirring device, heating to 60 ℃, adding 1g of activated carbon, stirring for 2 hours, carrying out vacuum filtration while the liquid is hot, collecting filtrate, heating and distilling under negative pressure, and condensing and recovering n-heptane. And cooling the concentrated solution to-10 ℃, and performing suction filtration to obtain 1.1g of white solid, namely the ergosterol crude product. The time taken for concentration and crystallization was 4 hours.
The ergosterol extraction was 0.11% and the purity was analyzed to be 88%. The extraction time is greatly shortened, and the time from feeding to obtaining the crude product of the ergosterol is shortened to 7 hours, wherein the time for obtaining the ergosterol extract is 13 hours. The ergosterol product is observed to be white powder in appearance and slightly poor in crystal form.
Example 4
(1) Extraction: weighing 1kg of penicillin fermentation residues, adding into an extraction tank, adding 1.2kg of ethanol, heating to maintain the temperature at 58 ℃, adding 50g of sodium hydroxide, and stirring for 4 hours. 1.2kg of n-heptane was added thereto, and the mixture was heated to maintain the temperature at 50 ℃ and stirred for 3 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the materials after the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing for layering, collecting upper layer light phase liquid, and recovering a lower layer solvent.
(3) Decoloring and crystallizing: and (3) adding the upper layer light phase liquid collected in the filtering and phase splitting in the step (2) into a decoloring tank with a stirring device, heating to 60 ℃, adding 1g of activated carbon, stirring for 2 hours, carrying out vacuum filtration while the liquid is hot, collecting filtrate, heating and distilling under negative pressure, and condensing and recovering n-heptane. And cooling the concentrated solution to-10 ℃, and performing suction filtration to obtain 1.1g of white solid, namely the ergosterol crude product. The time taken for concentration and crystallization was 4 hours.
The ergosterol extraction was 0.11% and the purity was analyzed to be 85%. The extraction time is greatly shortened, and the time from feeding to obtaining the crude product of the ergosterol is shortened to 13 hours, wherein the time for obtaining the ergosterol extract is 7 hours. The ergosterol product is observed to be white powder in appearance and slightly poor in crystal form.
Example 5
(1) Extraction: weighing 1kg of penicillin fermentation residues, adding into an extraction tank, adding 1.2kg of methanol, heating to maintain the temperature at 58 ℃, adding 50g of sodium hydroxide, and stirring for 4 hours. 1.2kg of n-heptane was added thereto, and the mixture was heated to maintain the temperature at 50 ℃ and stirred for 3 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the material subjected to the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing and layering, collecting upper layer light phase liquid, and recovering a lower layer solvent.
(3) Decoloring and crystallizing: and (3) adding the upper layer light phase liquid collected in the filtering and phase splitting in the step (2) into a decoloring tank with a stirring device, heating to 60 ℃, adding 1g of activated carbon, stirring for 2 hours, carrying out vacuum filtration while the liquid is hot, collecting filtrate, heating and distilling under negative pressure, and condensing and recovering n-heptane. And cooling the concentrated solution to-10 ℃, and performing suction filtration to obtain 1.2g of white solid, namely the ergosterol crude product. The time taken for concentration and crystallization was 4 hours.
The ergosterol extraction was 0.12% and the purity was analyzed to be 90%. The extraction time is greatly shortened, and the time from feeding to obtaining the crude product of the ergosterol is shortened to 13 hours, wherein the time for obtaining the ergosterol extract is 7 hours. The ergosterol product is observed to be white powder in appearance and slightly poor in crystal form.
Example 6
(1) Extraction: weighing 10kg of penicillin fermentation residues, adding into an extraction tank, adding 12kg of methanol, heating to maintain the temperature at 60 ℃, adding 200g of sodium hydroxide, and stirring for 3 hours. 8kg of n-heptane was added thereto, and the mixture was heated to maintain the temperature at 55 ℃ and stirred for 2 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the material subjected to the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing and layering, collecting upper layer light phase liquid, and recovering a lower layer solvent.
(3) Decoloring and crystallizing: and (3) adding the upper layer light phase liquid collected in the filtering and phase splitting of the step (2) into a decoloring tank with a stirring device, heating to 65 ℃, adding 1g of activated carbon, and stirring for 2 hours. Vacuum filtering, collecting filtrate, distilling the collected filtrate under negative pressure, and condensing to recover n-heptane. Cooling the concentrated solution to 10 ℃ at the cooling speed of 0.5 ℃/min, and performing suction filtration to obtain 10.5g of white solid, namely the ergosterol crude product. The time required for concentration and crystallization was 2 hours.
(4) And (3) recrystallization: and (3) adding the crude product obtained in the step (3) into a recrystallization container with 800g of recrystallization solvent, heating the recrystallization solvent to 50 ℃ until the crude product is completely dissolved, cooling to-10 ℃ at a cooling speed of 1 ℃/min, carrying out suction filtration to obtain white solid, and carrying out vacuum drying to obtain 9.4g of product, namely the ergosterol product. Recrystallization took 4 hours.
The extraction rate of ergosterol is 0.094%, and the purity of the product analyzed is 98%. The extraction time is greatly shortened, and the time from feeding to obtaining the crude product of the ergosterol is shortened to 13 hours, wherein the time for obtaining the ergosterol extract is 5 hours. The ergosterol product is observed to have bright appearance and good crystal form.
Example 7
(1) Extraction: weighing 15kg of penicillin fermentation residues, adding into an extraction tank, adding 900g of solid sodium hydroxide, adding 20kg of methanol, heating to maintain the temperature at 55 ℃, and stirring for 3 hours. Adding 18kg of n-heptane, heating and maintaining the temperature at 55-60 ℃, and stirring for 3 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the materials after the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing for layering, collecting upper layer light phase liquid, and recovering a lower layer solvent.
(3) Decoloring and crystallizing: and (3) adding the upper layer light phase liquid collected in the filtering and phase splitting of the step (2) into a decoloring tank with a stirring device, heating to 65 ℃, adding 8g of active carbon, and stirring for 1 hour. Vacuum filtering, collecting filtrate, distilling the collected filtrate under negative pressure, and condensing to recover n-heptane. The concentrate produced by distillation was collected. Cooling the concentrated solution to 5 ℃ at the cooling rate of 1 ℃/min, and filtering to obtain 30.5g of white solid, namely the ergosterol crude product. The time required for concentration and crystallization was 3 hours.
(4) And (3) recrystallization: and (3) adding the crude product obtained in the step (3) into a recrystallization container with 800g of recrystallization solvent, heating the recrystallization solvent to 60 ℃ until the crude product is completely dissolved, cooling to-10 ℃ at a cooling speed of 0.5 ℃/min, performing suction filtration to obtain a white solid, and performing vacuum drying to obtain 14.5g of product, namely the ergosterol product. Recrystallization took 4 hours.
The extraction rate of ergosterol is 0.097%, and the purity of the product analyzed is 98.5%. The extraction time is greatly shortened, and the time from feeding to obtaining the crude product of the ergosterol is shortened to 14 hours, wherein the time for obtaining the ergosterol extract is 6 hours. The ergosterol product is observed to have bright appearance and good crystal form.
Example 8
(1) Extraction: weighing 15kg of penicillin fermentation residues, adding into an extraction tank, adding 900g of solid sodium hydroxide, adding 20kg of methanol, heating to maintain the temperature at 58 ℃, and stirring for 3 hours. 15kg of n-heptane was added, and the mixture was heated to maintain the temperature at 55 to 60 ℃ and stirred for 3 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the material subjected to the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing and layering, collecting upper layer light phase liquid, and recovering a lower layer solvent.
(3) Decoloring and crystallizing: and (3) adding the upper layer light phase liquid collected in the filtering and phase splitting of the step (2) into a decoloring tank with a stirring device, heating to 70 ℃, adding 8g of active carbon, and stirring for 1 hour. Vacuum filtering, collecting filtrate, distilling the collected filtrate under negative pressure, and condensing to recover n-heptane. The concentrate produced by distillation was collected. And cooling the concentrated solution to 5 ℃ at the cooling speed of 1 ℃/min, and performing suction filtration to obtain 33.2g of white solid, namely the ergosterol crude product. The time required for concentration and crystallization was 3 hours.
(4) And (3) recrystallization: and (3) adding the crude product obtained in the step (3) into a recrystallization container with 800g of recrystallization solvent, heating the recrystallization solvent to 60 ℃ until the crude product is completely dissolved, cooling to-20 ℃ at a cooling speed of 0.5 ℃/min, performing suction filtration to obtain white solid, and performing vacuum drying to obtain 27.5g of product, namely the ergosterol product. Recrystallization took 5 hours.
The extraction rate of ergosterol is 0.183%, and the purity of the product analyzed is 99%. The extraction time is greatly shortened, and the time from feeding to obtaining the crude ergosterol product is shortened to 15 hours, wherein the time for obtaining the ergosterol extract is 6 hours. The ergosterol product is observed to have bright appearance and good crystal form.
Example 9
(1) Extraction: weighing 10kg of penicillin fermentation residues, adding the penicillin fermentation residues into an extraction tank, adding 12kg of methanol, heating to maintain the temperature at 55 ℃, adding 700g of solid sodium hydroxide, stirring for 4 hours, then adding 12kg of n-heptane, heating to maintain the temperature at 55-60 ℃, and stirring for 3 hours.
(2) Filtering and phase separation: and (2) carrying out vacuum filtration on the material subjected to the extraction reaction in the step (1), collecting filtrate, pumping the filtrate into a phase separation tank, standing and layering, collecting upper layer light phase liquid, and recovering a lower layer solvent.
(3) Decoloring and crystallizing: and (3) adding the upper layer light phase liquid collected in the filtering and phase splitting of the step (2) into a decoloring tank with a stirring device, maintaining the temperature at 50 ℃, adding 10g of activated carbon, stirring for 1 hour, filtering while hot, collecting filtrate, heating and distilling the collected filtrate under negative pressure, and condensing to recover n-heptane. And cooling the concentrated solution to-10 ℃, and filtering to obtain 20g of white solid, namely the ergosterol crude product. The time required for concentration and crystallization was 3 hours.
(4) And (3) recrystallization: and (3) adding the crude product obtained in the step (3) into a recrystallization container with 800g of recrystallization solvent, heating the recrystallization solvent to 65 ℃ until the crude product is completely dissolved, cooling to-10 ℃ at a cooling speed of 0.5 ℃/min, performing suction filtration to obtain white solid, and performing vacuum drying to obtain 12.5g of product, namely the ergosterol product. Recrystallization took 4 hours.
The extraction rate of ergosterol is 0.125%, and the purity of the product analyzed is 98.5%. The extraction time is greatly shortened, and the time from feeding to obtaining the crude ergosterol product is shortened to 15 hours, wherein the time for obtaining the ergosterol extract is 7 hours. The ergosterol product is observed to have bright appearance and good crystal form.
Example 10 (comparative example to example 5)
According to the process steps and reaction equipment disclosed in the prior art CN201810432608, by referring to example 3, penicillin fermentation mushroom residue is used as a raw material, and a crude ergosterol product is prepared under the condition that the same raw material formula, the same solvent, the same extraction agent and other operation parameters are selected in patent example 5, so that the improvement effect of the process disclosed by the patent is verified.
(1) Saponification: weighing 1kg of penicillin fermentation residues, adding the penicillin fermentation residues into a saponification reaction vessel, adding 1.2kg of methanol, heating to maintain the temperature at 58 ℃, adding 50g of sodium hydroxide, and stirring for 18 hours. Then cooled to room temperature.
(2) And (3) filtering I: carrying out vacuum filtration on the material in the step (1), and collecting 0.5kg of filter cake; recovering the filtrate.
(3) Extraction: adding 0.5kg of the filter cake in the step (2) into a container with stirring, adding 1.2kg of n-heptane, then adding, and heating to maintain the temperature at 50 ℃ for extraction for 18 hours.
(4) And (II) filtering: and (4) carrying out vacuum filtration on the material in the step (3), and collecting filtrate.
(5) And (3) distillation: and (4) heating and distilling the filtrate collected in the step (4) at normal pressure, and condensing to recover n-heptane. The residue was cooled to room temperature and filtered to give crude ergosterol product.
(6) And (3) decoloring: and (3) adding the crude product obtained in the step (5) into a closed container, adding 600g of trichloromethane, heating to 50 ℃, stirring until the trichloromethane is completely dissolved, adding 1g of activated carbon, and stirring for 2 hours.
(7) And (3) crystallization: and (4) filtering the mixture obtained in the step (6) while the mixture is hot, collecting filtrate, cooling the filtrate to-10 ℃ at the cooling speed of 0.5 ℃/min, and performing suction filtration to obtain 1.0g of white solid, namely the ergosterol crude product. The time taken for concentration and crystallization was 4 hours.
The ergosterol extraction was 0.10% and the purity was analyzed to be 87%. From the feeding to the obtaining of the ergosterol crude product for 40 hours, the time for obtaining the ergosterol extract is 36 hours. The ergosterol product is observed to be white powder in appearance and slightly poor in crystal form.
Example 11
In order to examine the extraction effect of different extractants, the applicant selects ergosterol with the purity of 98.5%, and respectively dissolves in three solvents of n-heptane, petroleum ether and n-hexane, and observes the solubility experiment of the ergosterol dissolved in the 3 solvents at different temperatures by controlling the temperature, and the research results are shown in table 1, table 2 and table 3.
TABLE 1 solubility of ergosterol in Petroleum Ether
Serial number | Temperature of | Solute (ergosterol) | Solvent (Petroleum ether) | Solubility in |
1 | 21℃ | 86.0mg | 100.0g | 0.860×10-3 |
2 | 29℃ | 195.5mg | 100.0g | 1.955×10-3 |
3 | 41℃ | 298.7mg | 100.0g | 2.987×10-3 |
4 | 45℃ | 357.3mg | 100.0g | 3.573×10-3 |
5 | 50℃ | 618.4mg | 100.0g | 6.184×10-3 |
6 | 57℃ | 771.0mg | 100.0g | 7.710×10-3 |
TABLE 2 solubility of ergosterol in n-heptane
Serial number | Temperature of | Solute (ergosterol) | Solvent (n-heptane) | Solubility in |
1 | 21℃ | 0.100.1g | 100.0g | 1.01×10-3 |
2 | 29℃ | 0.205.0g | 100.0g | 2.05×10-3 |
3 | 41℃ | 0.324.3g | 100.0g | 3.24×10-3 |
4 | 45℃ | 0.445.3g | 100.0g | 4.45×10-3 |
5 | 50℃ | 0.762.3g | 100.0g | 7.32×10-3 |
6 | 60℃ | 1.0163g | 100.0g | 10.16×10-3 |
TABLE 3 solubility of ergosterol in n-hexane
Serial number | Temperature of | Solute (ergosterol) | Solvent (n-hexane) | Solubility in |
1 | 21℃ | 62.2mg | 100.0g | 0.62×10-3 |
2 | 29℃ | 167.2mg | 100.0g | 1.67×10-3 |
3 | 41℃ | 265.9mg | 100.0g | 2.65×10-3 |
4 | 45℃ | 340.2mg | 100.0g | 3.40×10-3 |
5 | 50℃ | 565.2mg | 100.0g | 5.65×10-3 |
Applicants have found that multiple factors need to be considered in selecting an extractant: the extractant not only has extraction, but also has double functions of dissolution and extraction. The selection standard is 1) good solubility to ergosterol and small solubility to high protein and other impurities; 2) can be layered with solvent water solution, and is convenient for recovering the extractant. The applicant has found, through comparative studies, that the best results are obtained by selecting n-heptane as the extractant.
As can be seen from the solubility data in table 1, table 2, table 3: the ergosterol has the greatest solubility in n-heptane at the same temperature, so the extractant is chosen to be n-heptane. Meanwhile, 50 ℃ was selected as the optimum extraction operation temperature, considering that in this patent, saponification and extraction were performed in the same reaction vessel, and the boiling point of methanol, which is a solvent in the saponification reaction, was 64.7 ℃ while the boiling point of n-heptane, which is an extractant, was 98 ℃, in order to reduce energy consumption and prevent boiling of methanol during the reaction. Therefore, the n-heptane extraction is comprehensively considered and selected, the extraction temperature is 50 ℃, the extraction effect is considered, the power cost and the solvent loss are considered, and the method is more economical and cost-effective.
EXAMPLES 1-10 comparative analysis of extraction results
The results of the ergosterol extraction tests of examples 1-10 are summarized and made in Table 4 to analyze the effect of different extraction processes on the extraction yield and purity of the product.
TABLE 4 examples 1-10 comparison of results of ergosterol extraction studies
(1) The feasibility of the one-step extraction of the patent is as follows: the extraction results of the comparative example 1 and the example 2 in the table 4 show that the ergosterol extracted by the fermentation mushroom residue for the second time is very limited, the extraction rate is increased from 0.07% to 0.075%, and the increase of the extraction rate is very little, which indicates that the ergosterol extracted by the fermentation mushroom residue process and the extraction tank provided by the patent has a good one-step extraction effect, can fully complete the extraction of the ergosterol in the fermentation mushroom residue, the secondary extraction affects the industrial production efficiency, the raw material consumption is increased, the energy consumption is also increased, and the industrial production is uneconomical. In addition, the secondary extraction is added, and the quality and the purity of the crude ergosterol are not contributed. Therefore, the ergosterol is extracted by the one-step method by adopting the process and the extraction tank of the patent with good effect.
(2) Selecting a solvent: from the comparison of the extraction results of examples 3, 4 and 5 in table 4, it was found that chloroform, ethanol and methanol can be used as the solvent for the saponification reaction of extracting ergosterol from fermentation broth, and methanol is selected as the solvent, so that the extraction rate of ergosterol is 0.12% at the highest, and the product purity is 90%, and the best effect is obtained. The solvent has two functions, namely, the solvent can dissolve part of protein and polysaccharide and reduce the amount of the protein and polysaccharide counted in an extracting agent so as to improve the purity of the ergosterol product, and the solvent plays a wall breaking role so as to enhance the saponification effect and be beneficial to extracting the ergosterol. The effect of methanol in both aspects is better when n-heptane is selected as the extractant.
In addition, from the comparison of the extraction reaction time data of 1-9 in table 4, it is found that the preparation time of the ergosterol crude product is greatly reduced by adopting the process and the extraction tank equipment of the patent under the condition of selecting n-heptane as the extractant, and the preparation time can be basically shortened to 9 hours by selecting the combination of methanol as the solvent and n-heptane as the extractant, which indicates that the extraction efficiency of the product is higher by adopting the technology of the patent.
(3) And (3) selecting a recrystallization solvent: compared with the refining and purifying effects of 4 solvents of toluene, ethanol, ethyl acetate, ethanol and toluene mixed solution, the extraction data of the embodiment 6-9 in the table 4 show that the two components of the ethanol and toluene mixed solution are selected for the recrystallization of the ergosterol, the effect is the best, the extraction rate of the ergosterol is up to 0.183%, and the product purity is up to 99%.
(4) This patent contrasts with the prior art (CN201810432608 process). From the comparison of the extraction result data of example 5 and example 10 in table 4, it is found that, not only is the extraction rate of ergosterol product high (0.12% in example 5) and the product purity high (90% in example 5) by using the process and extraction tank of the present invention in one step, but also the extraction time of ergosterol is greatly shortened (the preparation time of crude ergosterol product is 9 hours in example 5 and 36 hours in example 10), which indicates that the effect of ergosterol extraction by using the process and extraction tank of the present invention in one step is improved obviously, and for industrial production, not only the production efficiency is improved, but also the energy consumption can be reduced, the product cost can be reduced, and the market competitiveness of the product can be improved. The extraction tank capable of simultaneously completing saponification and extraction is designed, the heavy phase balance tank is matched to eliminate impact and damage to phase separation in the operation process of pumping materials, filtering is not needed before extraction, the process flow is simplified, energy consumption is reduced, the reaction time is greatly shortened, and meanwhile, the loss possibly caused by filtering in the prior art is avoided, so that the extraction rate and the purity of the product can be improved.
The above-mentioned contents are only for illustrating the technical idea of the present invention, and the protection scope of the present invention is not limited thereby, and any modification made on the basis of the technical idea of the present invention falls within the protection scope of the claims of the present invention.
Claims (10)
1. The utility model provides a device for ergosterol is drawed in saponification, its characterized in that, is including drawing the jar, draw jar barrel and toper lower barrel on the cylindricality of connecting from top to bottom, the tank deck of drawing the jar sets up the feed inlet, the tank bottoms of drawing the jar has seted up the discharge gate, it is equipped with agitating unit to draw jar central authorities, be provided with on the inner wall of drawing the jar and keep off the flow board.
2. The device for saponification extraction of ergosterol according to claim 1, further comprising a heavy phase balancing tank, wherein the heavy phase balancing tank is a closed cylindrical barrel, the top of the heavy phase balancing tank is provided with an exhaust port, the middle or upper part of the cylindrical barrel of the heavy phase balancing tank is provided with a feed inlet, the bottom center of the heavy phase balancing tank is provided with a heavy phase discharge port, and the feed inlet of the heavy phase balancing tank is communicated with the discharge port of the extraction tank through a pipeline.
3. The device for saponification extraction of ergosterol according to claim 1 or 2, wherein the stirring device comprises a stirring shaft, one end of the stirring shaft is connected with a stirring motor, at least one group of stirring blades is arranged at the upper part of the stirring shaft in the upper cylinder, and at least one group of stirring blades is arranged at the lower part of the stirring shaft in the lower cylinder.
4. The device for saponification extraction of ergosterol according to claim 3, wherein the upper part of the stirring shaft in the upper cylinder is provided with a first blade set, a second blade set and a third blade set in sequence from top to bottom, and the lower part of the stirring shaft in the lower cylinder is provided with a fourth blade set and a fifth blade set.
5. The apparatus for saponification extraction of ergosterol according to claim 4, wherein the blade sets comprise two symmetrical blade-shaped blades, and the blades of the two adjacent blade sets form an anti-symmetrical arrangement with the central axis of the stirring shaft.
6. The device for saponification extraction of ergosterol according to claim 1, wherein a plurality of flow baffles are vertically arranged on the inner wall of the upper cylinder of the extraction tank at intervals, and are circumferentially arranged at equal intervals and angles along the inner wall of the upper cylinder of the extraction tank.
7. The device for saponification extraction of ergosterol according to claim 1 or 6, wherein a heating device is disposed on the inner wall of the extraction tank and/or the outer wall of the upper cylinder, the heating device comprises a heating coil disposed on the inner wall of the upper cylinder of the extraction tank, a steam distribution plate and a condensed water collection plate mounted on the outer wall of the upper cylinder of the extraction tank, and the steam distribution plate is communicated with the condensed water collection plate through the heating coil.
8. An apparatus for saponification extraction of ergosterol according to claim 1 or 6, wherein the extraction tank uses a variable frequency speed motor to control the stirring device; an electric butterfly valve, a sight glass and an electric ball valve are sequentially arranged at a discharge port at the bottom of the extraction tank through pipelines, a light phase discharge pipeline and a cleaning pipeline are sequentially communicated on the pipeline between the electric butterfly valve and the sight glass, and the light phase discharge pipeline is connected with a light phase pump and used for conveying light phase extracting solution; the cleaning pipeline is used for cleaning a discharge pipeline behind an electric butterfly valve at the bottom of the extraction tank.
9. The device for saponification extraction of ergosterol according to claim 2, wherein the exhaust port of the heavy phase equilibrium tank is communicated with the feed inlet of the extraction tank through an overflow pipe, and the barrel body of the heavy phase equilibrium tank is provided with a sight glass port.
10. An apparatus for the saponification extraction of ergosterol according to claim 1 or 2, wherein the operating temperature of the saponification and extraction reaction in the extraction tank is 20-70 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011101897.9A CN112107881B (en) | 2020-09-29 | 2020-09-29 | Device for extracting ergosterol through saponification |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011101897.9A CN112107881B (en) | 2020-09-29 | 2020-09-29 | Device for extracting ergosterol through saponification |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112107881A true CN112107881A (en) | 2020-12-22 |
CN112107881B CN112107881B (en) | 2023-12-22 |
Family
ID=73793945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011101897.9A Active CN112107881B (en) | 2020-09-29 | 2020-09-29 | Device for extracting ergosterol through saponification |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112107881B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113617295A (en) * | 2021-08-18 | 2021-11-09 | 中国科学院广州地球化学研究所 | Reaction furnace and material production process |
CN113861259A (en) * | 2020-10-01 | 2021-12-31 | 内蒙古麦维生物科技有限公司 | Saponification extraction process |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2297912A1 (en) * | 1975-01-14 | 1976-08-13 | Inst Biosinteza Belkovikh | Ergosterol and ubiquinone 9 prodn - by hydrolysing a biolipid fraction from the biomass of yeast strains |
US4406789A (en) * | 1980-04-21 | 1983-09-27 | Establissemens Andre Bardet S.A. | Apparatus and installation for separating immiscible liquids with different specific gravities |
CN1118278A (en) * | 1995-06-12 | 1996-03-13 | 张贺忠 | Multifunctional continuous extracting pot |
CN1843612A (en) * | 2006-03-13 | 2006-10-11 | 江南大学 | Multifunctional post-extraction tank for extracting biological reaction product |
CN202478645U (en) * | 2012-01-10 | 2012-10-10 | 成都科尔医药技术有限公司 | Ultrasonic extraction and concentration circulation device |
CN204447383U (en) * | 2015-01-27 | 2015-07-08 | 中国人民解放军63977部队 | A kind of extraction equipment |
CN104974219A (en) * | 2015-07-14 | 2015-10-14 | 河北智同生物制药有限公司 | Convenient ossotide alcohol precipitation tank and application method thereof |
CN205084450U (en) * | 2015-11-05 | 2016-03-16 | 山西黄河中药有限公司 | A multipotency draws jar for traditional chinese medicine draws |
CN205313446U (en) * | 2016-01-01 | 2016-06-15 | 三峡大学 | Chestnut shell pigment extraction device |
CN208726807U (en) * | 2018-03-28 | 2019-04-12 | 盐城市东港药物化工发展有限公司 | A kind of device that two-phase is automatically subjected to phase splitting |
CN110038321A (en) * | 2019-05-27 | 2019-07-23 | 湖南中医药大学 | A kind of traditional Chinese medicine extraction device |
CN111618075A (en) * | 2020-06-16 | 2020-09-04 | 无锡厚德石化工程设计有限公司 | Comprehensive treatment device and method for aged resin |
-
2020
- 2020-09-29 CN CN202011101897.9A patent/CN112107881B/en active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2297912A1 (en) * | 1975-01-14 | 1976-08-13 | Inst Biosinteza Belkovikh | Ergosterol and ubiquinone 9 prodn - by hydrolysing a biolipid fraction from the biomass of yeast strains |
US4406789A (en) * | 1980-04-21 | 1983-09-27 | Establissemens Andre Bardet S.A. | Apparatus and installation for separating immiscible liquids with different specific gravities |
CN1118278A (en) * | 1995-06-12 | 1996-03-13 | 张贺忠 | Multifunctional continuous extracting pot |
CN1843612A (en) * | 2006-03-13 | 2006-10-11 | 江南大学 | Multifunctional post-extraction tank for extracting biological reaction product |
CN202478645U (en) * | 2012-01-10 | 2012-10-10 | 成都科尔医药技术有限公司 | Ultrasonic extraction and concentration circulation device |
CN204447383U (en) * | 2015-01-27 | 2015-07-08 | 中国人民解放军63977部队 | A kind of extraction equipment |
CN104974219A (en) * | 2015-07-14 | 2015-10-14 | 河北智同生物制药有限公司 | Convenient ossotide alcohol precipitation tank and application method thereof |
CN205084450U (en) * | 2015-11-05 | 2016-03-16 | 山西黄河中药有限公司 | A multipotency draws jar for traditional chinese medicine draws |
CN205313446U (en) * | 2016-01-01 | 2016-06-15 | 三峡大学 | Chestnut shell pigment extraction device |
CN208726807U (en) * | 2018-03-28 | 2019-04-12 | 盐城市东港药物化工发展有限公司 | A kind of device that two-phase is automatically subjected to phase splitting |
CN110038321A (en) * | 2019-05-27 | 2019-07-23 | 湖南中医药大学 | A kind of traditional Chinese medicine extraction device |
CN111618075A (en) * | 2020-06-16 | 2020-09-04 | 无锡厚德石化工程设计有限公司 | Comprehensive treatment device and method for aged resin |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113861259A (en) * | 2020-10-01 | 2021-12-31 | 内蒙古麦维生物科技有限公司 | Saponification extraction process |
CN113617295A (en) * | 2021-08-18 | 2021-11-09 | 中国科学院广州地球化学研究所 | Reaction furnace and material production process |
Also Published As
Publication number | Publication date |
---|---|
CN112107881B (en) | 2023-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112142815B (en) | Method and system for extracting ergosterol from fermentation fungus residues | |
CN112107881B (en) | Device for extracting ergosterol through saponification | |
US11840501B2 (en) | Xylitol preparation device integrating evaporation, crystallization and centrifugal separation and control method thereof | |
CN102307982B (en) | Method of preparing a liquid extract of cereal grain and apparatus suitable for use in such method | |
CN208081899U (en) | Beta-cyclodextrin isolates and purifies device | |
CN216062109U (en) | Device for saponifying and extracting ergosterol | |
CN105483372B (en) | A kind of reaction, separation, washing, evaporation and drying integrated device and method | |
CN111149893B (en) | High-concentration precipitate-free concentrated tea juice production system and production process applying same | |
CN214735487U (en) | System for extracting ergosterol from fermentation mushroom dregs | |
CN208465245U (en) | A kind of flavouring essence for tobacco processing extraction equipment | |
CN107955084B (en) | Reaction tank deslagging and separating system special for extracting chlorella polysaccharide | |
CN116284489A (en) | Method for extracting and purifying konjak glucomannan and application of konjak glucomannan in gel food | |
CN114504841B (en) | Resveratrol extraction system | |
CN208574259U (en) | A kind of extraction system of baikal skullcap root | |
CN116808625A (en) | Coffee extraction concentration system | |
CN110404373A (en) | The preparation producing line of high-purity benzophenone | |
CN110523325A (en) | A kind of biology extraction filter device | |
CN211226970U (en) | Multifunctional device for producing gamma-aminobutyric acid | |
CN213313704U (en) | Processing device for cholesterol separation | |
CN101690737A (en) | Novel double-solvent fast medicinal-liquor preparation process | |
CN209348631U (en) | A kind of solid catalysis esterification production system | |
CN202283420U (en) | Drug extraction tank | |
CN209597852U (en) | A kind of restaurant garbage treating system | |
CN208104363U (en) | A kind of pure mellow wine preparation system | |
CN207899513U (en) | A kind of wet disintegrating apparatus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |